Add BrightSurf on Google Email

APSHO and Hope Foundation launch educational courses for advanced practitioners in oncology care

The Advanced Practitioner Society of Hematology and Oncology (APSHO) has launched two new educational courses for advanced practitioners in oncology care, developed in collaboration with The Hope Foundation for Cancer Research. The self-paced online courses provide practical, evidence-informed education focused on real-world clinical p...

Broad genomic testing linked to longer survival in advanced lung cancer according to new study in JNCCN

A new study published in JNCCN found that comprehensive biomarker testing before treatment for advanced lung cancer was associated with patients living longer. Broad-based genomic sequencing helped identify a wider range of tumor biomarkers, guiding targeted treatment and improving survival outcomes.

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·DateNov 12, 2026

Tumours survive a stalled respiratory chain by draining surplus NADH. Plug the drain and metformin turns lethal

A study found that metformin kills cancer cells by blocking a mitochondrial-cytosolic circuit that drains surplus NADH, reducing reductive stress. The circuit, involving pyruvate carboxylase, mitochondrial malate dehydrogenase, and malic enzyme 1, is a key player in cancer cells' ability to survive under metabolic stress.

SourceInnovation Press·JournalThe Innovation·TypeExperimental study·DateNov 11, 2026

Engineered Salmonella kills tumours. A salt-triggered gel keeps it from poisoning the mice

The study found that a salt-triggered gel containing engineered Salmonella reduced tumour growth by shrinking tumours as well as free bacteria, cutting weight loss by 82% and reversing liver and spleen damage. The gel also delivered the bacteria to the tumours, avoiding poisoning, and showed promise in treating melanoma and other cancers.

SourceInnovation Press·JournalThe Innovation·TypeObservational study·DateNov 11, 2026

AI model combines scans and tissue clues to assess survival risk in esophageal cancer

A recent study developed an AI framework, MENISA, combining CT scans, digital tissue images, and tumor microenvironment clues to estimate survival risk in esophageal squamous cell carcinoma patients. The model distinguished groups with different survival outcomes and performed better than models relying on single information sources.

SourceInternational Society for Health Data Science·JournaliMetaMed·TypeObservational study·DateNov 9, 2026

Wash U Medicine Cancer study professional recognized with Clinical Research Integrity Award by Alliance for Clinical Trials in Oncology

Jennifer Frederick, an oncology clinical trial organizer at Wash U Medicine, received the 2026 Alliance Clinical Research Professionals Research Integrity Service Award for her dedication to helping cancer patients access clinical trials. Her work ensures that trials run smoothly and safely, with a focus on patient advocacy and compass...

Tumor–host metabolic interactions in the microenvironment and macroenvironment: Mechanisms and targeting strategies

This review systematically elucidates the interconnected interplay between the tumor microenvironment and macroenvironment, regulating metabolic reprogramming in tumor cells. Emerging precision therapeutic strategies targeting metabolism, such as nanotechnology and exercise, are proposed to develop more effective holistic treatment str...

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateOct 29, 2026

Rising rates of colorectal cancer found in nearly all age groups

A new study published in NEJM Evidence found that colorectal cancer rates are rising across younger and older age groups, with younger adults now at the highest risk. The study found that the age-adjusted incidence rate fell in the early 2000s but rose to 38.3 in 2023, with the sharpest increase among 45-49-year-olds. The researchers w...

SourceUniversity of Chicago Medical Center·JournalNEJM Evidence·TypeData/statistical analysis·DateOct 27, 2026

ASTRO updates guideline on shorter-course radiation therapy for localized prostate cancer

The updated guideline recommends moderate hypofractionation over conventional fractionation for patients across all prostate cancer risk groups who choose EBRT, supported by high-quality randomized data showing comparable outcomes, side effects and quality of life. Ultrahypofractionation is also strongly recommended as a standard optio...

SourceAmerican Society for Radiation Oncology·JournalPractical Radiation Oncology·DateOct 27, 2026

International tumor board explores personalized treatment strategies for colon cancer without measurable disease

The case report highlights the challenges of monitoring residual disease in stage IIIc colon cancer, where conventional imaging shows no measurable tumor but circulating tumor DNA and DNA methylation patterns suggest molecular residual disease. Molecular profiling and international collaboration may help guide treatment decisions in su...

SourceImpact Journals LLC·JournalOncotarget·TypeCase study·DateOct 26, 2026

Targeting the gut-liver axis: New review explores microbial modulation to enhance immunotherapy in hepatocellular carcinoma

A new review examines how gut microbiota and metabolites reshape liver immunity and propose strategies to overcome immunotherapy resistance. The review discusses four major directions of gut microbiota intervention, including probiotics, fecal microbiota transplantation, engineered bacteria, and metabolite-based interventions.

SourceImmunity & Inflammation·JournalImmunity & Inflammation·TypeSystematic review·DateOct 21, 2026

JACR study explores discrepancies among paid family and medical leave policies across U.S. academic and radiation oncology departments

A recent study found that paid family and medical leave policies are widely available but inconsistently implemented across US academic radiology and radiation oncology departments. Most programs require faculty to use vacation or sick time with variable allowance, and few employees utilized leave in the previous year.

SourceAmerican College of Radiology·JournalJournal of the American College of Radiology·TypeSurvey·DateOct 15, 2026

Chinese Medical Journal article review synthesizes molecular mechanisms, current therapeutics, and emerging strategies in esophageal cancer

This comprehensive review synthesizes molecular mechanisms, current therapeutics, and emerging strategies in esophageal cancer. The findings highlight breakthroughs in immunotherapy and promising future directions in targeted therapies.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateOct 14, 2026

Even highly curable childhood cancers take a substantial toll on families, according to new study from JNCCN

Families of children with B-cell acute lymphoblastic leukemia (B-ALL) experience substantial and lasting challenges, including household employment changes and marital status changes, beginning early after diagnosis. These challenges persist throughout treatment and have significant financial, social, and emotional impacts on families.

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·DateOct 13, 2026

Are young women receiving delayed care for breast cancer?

A study published in the journal CANCER found that young women with breast cancer experience delays in care, with lower income and younger age being the most common factors. These delays can lead to later stages of disease and more extensive treatment, impacting quality of life.

SourceWiley·JournalCancer·DateOct 12, 2026

NCCN highlights collaborations to improve global cancer outcomes during meetings in North America and Asia

NCCN has published regional cancer treatment guidelines for the Philippines, tailored to the local setting and regulatory environment. The guidelines reflect collaborations with global organizations, including the International Gynecologic Cancer Society and the Philippine Society of Medical Oncology, to improve access to high-quality ...

A formidable type of childhood cancer gets added to highly regarded library of treatment recommendations

The new NCCN Guidelines for Pediatric Bone Sarcoma focus on Ewing sarcoma and other undifferentiated round cell sarcomas, aiming to provide clear medical roadmaps for patients and their families. With a 5-year survival rate of 81% for early-stage diagnosis, these guidelines can help ensure teenagers receive optimal treatment and support.

New AI platform could help cancer survivors get personalized support between doctor visits

A new AI platform, Precision AI for Survivorship and Supportive Care, aims to personalize evidence-based support for cancer survivors navigating persistent side effects and other challenges after treatment. The platform uses machine-learning models to identify patterns associated with symptom burden and unplanned healthcare utilization...

SourceUniversity of Miami Miller School of Medicine·JournalTranslational Behavioral Medicine·DateSep 29, 2026